(R)-N-(2-(2-Fluoro-3-hydroxy-3-methylbutyl)-6-morpholino-1,1-dioxo-3H-1,2-benzothiazol-5-yl)pyrazolo[1,5-a]pyrimidine-3-carboxamide

ID: ALA4536154

PubChem CID: 129297531

Max Phase: Preclinical

Molecular Formula: C23H27FN6O5S

Molecular Weight: 518.57

Molecule Type: Unknown

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  CC(C)(O)[C@H](F)CN1Cc2cc(NC(=O)c3cnn4cccnc34)c(N3CCOCC3)cc2S1(=O)=O

Standard InChI:  InChI=1S/C23H27FN6O5S/c1-23(2,32)20(24)14-29-13-15-10-17(27-22(31)16-12-26-30-5-3-4-25-21(16)30)18(11-19(15)36(29,33)34)28-6-8-35-9-7-28/h3-5,10-12,20,32H,6-9,13-14H2,1-2H3,(H,27,31)/t20-/m1/s1

Standard InChI Key:  IJFSSJNDQGCBGQ-HXUWFJFHSA-N

Molfile:  

 
     RDKit          2D

 36 40  0  0  0  0  0  0  0  0999 V2000
   14.6352   -3.9044    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.3450   -4.3130    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.3439   -3.4939    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.0855   -5.0641    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   17.8750   -4.2758    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
   17.2976   -4.8522    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   17.3921   -3.6113    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   19.3647   -4.4353    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.0743   -4.0259    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.0715   -3.2032    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.3629   -2.7980    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.6566   -4.0264    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.6579   -3.2053    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.8774   -2.9504    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.7804   -4.4326    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   20.7797   -5.2507    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.4840   -5.6581    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.1935   -5.2519    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   22.1942   -4.4337    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.4854   -4.0218    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.7777   -2.7920    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   20.7746   -1.9748    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.4808   -1.5635    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.0654   -1.5688    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   22.3587   -0.5770    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   21.5601   -0.7501    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.7700   -1.2832    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   22.2233   -1.8906    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.4764   -2.6657    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   23.2757   -2.8345    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   23.8215   -2.2222    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   23.5656   -1.4495    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.5750   -3.6094    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.1647   -4.3161    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.9372   -5.0208    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   16.5710   -5.0251    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
  2  1  1  0
  3  2  1  0
  5  4  2  0
  6  5  2  0
 12  8  1  0
  8  9  2  0
  9 10  1  0
 10 11  2  0
 11 13  1  0
 12 13  2  0
 13 14  1  0
 14  7  1  0
  7  5  1  0
  5 12  1  0
 15 16  1  0
 15 20  1  0
 16 17  1  0
 17 18  1  0
 18 19  1  0
 19 20  1  0
  9 15  1  0
 10 21  1  0
 21 22  1  0
 22 23  1  0
 22 24  2  0
 23 28  2  0
 27 25  1  0
 25 26  2  0
 26 23  1  0
 27 28  1  0
 28 29  1  0
 29 30  2  0
 30 31  1  0
 31 32  2  0
 32 27  1  0
  7 33  1  0
 33 34  1  0
 34  2  1  0
  2 35  1  0
 34 36  1  1
M  END

Alternative Forms

  1. Parent:

    ALA4536154

    ---

Associated Targets(Human)

IRAK4 Tchem Interleukin-1 receptor-associated kinase 4 (5917 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 518.57Molecular Weight (Monoisotopic): 518.1748AlogP: 1.43#Rotatable Bonds: 6
Polar Surface Area: 129.37Molecular Species: NEUTRALHBA: 9HBD: 2
#RO5 Violations: 1HBA (Lipinski): 11HBD (Lipinski): 2#RO5 Violations (Lipinski): 2
CX Acidic pKa: 12.05CX Basic pKa: 0.42CX LogP: 0.71CX LogD: 0.71
Aromatic Rings: 3Heavy Atoms: 36QED Weighted: 0.50Np Likeness Score: -1.73

References

1. Rajapaksa NS, Gobbi A, Drobnick J, Do S, Kolesnikov A, Liang J, Chen Y, Sujatha-Bhaskar S, Huang Z, Brightbill H, Francis R, Yu C, Choo EF, DeMent K, Ran Y, An L, Emson C, Maher J, Wai J, McKenzie BS, Lupardus PJ, Zarrin AA, Kiefer JR, Bryan MC..  (2020)  Discovery of Potent Benzolactam IRAK4 Inhibitors with Robust in Vivo Activity.,  11  (3): [PMID:32184965] [10.1021/acsmedchemlett.9b00380]

Source